Esophageal squamous cell carcinoma (ESCC) is one of the most common
cancers worldwide.
Plasminogen activator inhibitor-1 (PAI-1), encoded by SERPINE1, is highly expressed in various types of
tumor tissues, which contributes to
cancer progression. The present study explored the role and underlying mechanisms of
PAI-1 in ESCC. We found that the
PAI-1 protein was extracellularly secreted more from ESCC cells with high
PAI-1 expression using Western blotting and
enzyme linked
immunosorbent assay (ELISA). Knockdown of SERPINE1 expression significantly inhibited the invasion and migration of ESCC KYSE150 and KYSE450 cell lines, which could be restored when adding exogenous human recombinant
PAI-1 into the culture medium of the cells stably expressing SERPINE1
shRNA. In vivo experiments showed that SERPINE1 knockdown significantly inhibited xenograft growth and lung
metastasis of ESCC cells. Molecular analysis demonstrated that
PAI-1 activated AKT and ERK signaling pathways. Co-immunoprecipitation (Co-IP) assays identified that
PAI-1 may interact with the membrane
receptor LDL receptor related
protein 1 (LRP1). These results indicated that overexpression of
PAI-1, through interacting with LRP1, might enhance invasion and migration of ESCC cells as well as promote ESCC progression.